Search Result for:
Myasthenia Gravis
Browse:
Category
Course Type
Credit type
My Role
AANEM Education Partners
Featured Courses
Sort By
Image For Activity Cover

12/15/2024- In this AANEM podcast, Carrie Ford, a CNCT and R.NCS.T. from the University of Utah's Jack Petajan EMG Lab, interviews Dr. Kyle Mahoney, an associate professor at the University of Utah, who provides a comprehensive explanation of neuromuscular junction transmission and the critical concept of the "safety factor." He breaks down complex neurophysiological concepts using accessible analogies, explaining how the safety factor serves as a built-in buffer that ensures reliable nerve-to-muscle signal transmission. The discussion covers normal neuromuscular junction function, the impact of various pathological conditions such as Lambert-Eaton Myasthenic Syndrome, myasthenia gravis, and ALS on neuromuscular transmission, and the clinical significance of repetitive nerve stimulation testing. Dr. Mahoney's clear explanations make these technically challenging concepts more approachable for healthcare professionals, particularly EMG technicians who may be less familiar with the underlying mechanisms of neuromuscular transmission. 24 min.

 No Credit
Image For Activity Cover
 100 CME available  100 CEU available
Image For Activity Cover
From 2023 Annual Meeting Session Content
 3 SA CME available  3 CEU available
Image For Activity Cover

Join us in this episode as Devon Rubin, MD, challenges Professor Erik Stalberg with an unknown case and discusses various EMG approaches to a patient with suspected neuromuscular junction disease. Watch Professor Stalberg grade Dr. Rubin’s single fiber pairs and hearing about single fiber EMG on dogs will surely make you smile!

 No Credit
Image For Activity Cover
 1 CME available  1 CEU available
Image For Activity Cover
12/13/2022 -  Dr. Elie Naddaf, MD interviews Dr. James Howard, MD about the use of complement and the neonatal Fc receptor inhibitors in myasthenia gravis, highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials.   1 hour 6 minutes
 No Credit
Image For Activity Cover
  • EMG/NCS and Risk of Bleeding
  • Needle EMG and the Risk of Pneumothorax
  • NM Complications of Immune Checkpoint Inhibitors
  • Percutaneous Sharp Injuries: Primary Prevention
  • Safety of Direct Oral Anticoagulants (DOACS) in Needle EMG
  • Statins and Immune-Mediated Necrotizing Myopathy
Image For Activity Cover
From 2022 Annual Meeting Session Content
 3 SA CME available  3 CEU available
Image For Activity Cover
 86.5 CME available  86.5 CEU available
Image For Activity Cover

12/16/2021- Dr. Katarzyna Ibanez interviews Dr. Timothy Dillingham on evaluation of persons with suspected lumbosacral and cervical radiculopathy.   39 minutes

 No Credit
Image For Activity Cover

11/3/2021-   Dr. Elahi Behzad interviews Dr. Michael H. Rivner on the clinical features of LRP4/agrin-antibody–positive Myasthenia Gravis.    21 minutes

 No Credit
Image For Activity Cover
 0.25 CME available  0.25 CEU available
Course 1 to 20 of 34


2621 Superior Drive NW
Rochester, MN

P 507.288.0100

F 507.288.1225

aanem@aanem.org

                   

© 2024 American Association of Neuromuscular & Electrodiagnostic Medicine
Powered By